The efficacy of a pectin-based raft-forming anti-reflux agent in endoscopy-negative reflux disease
Aflurax reduces heartburn in patients with endoscopy-negative gastro-oesophageal reflux disease (GORD) Patients with GORD have mainly postprandial reflux and low total acid exposure. No further treatment effect was found on day 29.
